Title | Total cells | ||
1 | Blood and immune development in human fetal bone marrow and Down syndrome Dataset 1: Fetal Bone Marrow (10x) cell type: CD14 monocyte expressed genes: SIGLEC9 Dataset 3: Fetal Bone Marrow (10x) - Down Syndrome cell type: CD14 monocyte expressed genes: SIGLEC9 Dataset 4: Human Fetal Bone Marrow (CITE-seq) cell type: CD14 monocyte expressed genes: SIGLEC9 | ||
2 | Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 Dataset 1: Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 cell type: classical Monocyte expressed genes: SIGLEC9 | ||
3 | Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer Dataset 1: Single-cell transcriptomic datasets of Renal cell carcinoma patients cell type: classical monocyte MHC-II-positive classical monocyte expressed genes: SIGLEC9 | ||
4 | Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia Dataset 1: Global dataset of infant KMT2Ar B-ALL cell type: CD14_Monocyte expressed genes: SIGLEC9 | ||
5 | Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy Dataset 1: Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy cell type: CD14+ Monocyte expressed genes: SIGLEC9 | ||
6 | Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 Dataset 1: Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 cell type: cM cM_Act_1006 cM_IFN_1006 expressed genes: SIGLEC9 |